Symbol: |
ECT2L
|
Description: |
epithelial cell transforming sequence 2 oncogene-like [Source:HGNC Symbol;Acc:21118]
|
Location: |
Chr6:139117063-139225207[+]
|
CRmiRSNP:
~ Export ~
|
Records:null
Compound |
CRmiRSNP |
SNP_sig |
Model |
Molecule |
Mol_sig |
Type |
Model : M1-Allele, M2-Recessive, M3-Additive, M4-Dominant
Total:0 Current:1
[First] [Prev] [Next] [Last]
|
Compound:
~ Export ~
|
Records:437
Gene |
Compound |
Gen_sig |
Exp_pattern |
ECT2L |
Everolimus |
0.001 |
Up |
ECT2L |
NSC 734201 |
0.031 |
Up |
ECT2L |
NSC 734631 |
0.01 |
Down |
ECT2L |
2-(4-morpholinophenylamino)-6-(2,6-dichlorophenyl)-8-methylp yrido[2,3-d]pyrimidin-7(8H)-one |
0.035 |
Down |
ECT2L |
6-(3-Bromopropyl)-5,6-dihydro-9-methyl-3-nitro-5,11-dioxo-11 H-indeno[1,2-c]isoquinoline |
0.038 |
Down |
ECT2L |
NSC 736154 |
0.009 |
Down |
ECT2L |
1,2-Dithiolan-3-yl-N-(3'-methoxyestra-1',3',5'(10')-triene-1 7'b-yl)pentanamide |
0.049 |
Down |
ECT2L |
NSC 736188 |
0.016 |
Down |
ECT2L |
6-(3-Aminopropyl)-5,6-dihyro-9-iodo-3-nitro-5,11-dioxo-11H-i ndeno[1,2-c]isoquinoline Hydrochloride |
0.032 |
Down |
ECT2L |
2-(4-chloro-2-methylphenoxy)-N-(4-chlorobenzo[d]thiazol-2-yl )acetamide |
0.001 |
Down |
ECT2L |
6-(3-Chloropropyl)-5,6-dihydro-2,3,9-trimethoxy-5,11-dioxo-1 1H-indeno[1,2-c]isoquinoline |
0.043 |
Down |
ECT2L |
NSC 737745 |
0.024 |
Down |
ECT2L |
1-(4-chlorophenyl)-3,3-diphenyl-1'-methylspiro[azetidin-2,3' =indoline]=2',4-dione |
0.013 |
Down |
ECT2L |
(-)-dactylolide |
0.026 |
Down |
ECT2L |
5,6-Dihydro-6-[3-(2-hydroxyethyl)amino-1-propyl]-3-nitro-5,11-dioxo-11H-indeno[1,2-c]isoquinoline Hydrochloride |
0.014 |
Down |
Expression pattern: Sensitivity / Resistance
Total:30 Current:28
First Prev Next Last 
|
SNP:
~ Export ~
|
Records:24
Total:2 Current:1
[First] [Prev]  Next Last 
|
miRNA:
~ Export ~
|
Records:null
Gene |
Gen_transcript |
miRNA |
miR_location |
Total:0 Current:1
[First] [Prev] [Next] [Last]
|